Dr. Kan Yonemori has specialized in early to late phase clinical development in breast, gynecologic cancer, sarcomas, other miscellaneous rare tumors and pan-tumor development. He is the expert for regulatory affairs based on his experience of ex-officer of PMDA and has Asian expert network in many countries.